Remood 0.5 mg+10 mg (Tablet)
Medicine Details
| Category | Details |
|---|---|
| Generic | Flupentixol melitracen |
| Company | Ibn sina pharmaceuticals ltd |
Indications
- Anxiety
- Depression
- Apathy
- Psychogenic depression
- Depressive neurosses
- Masked depression
- Psychosomatic affections accompanied by anxiety and apathy
- Menopausal depressions
- Dysphoria and depression in alcoholics and drug addicts
Pharmacology
Consists of flupentixol-a neuroleptic with anxiolytic and antidepressant properties and melitracen-a bipolar thymoleptic with activating properties.
Dosage & Administration
- Adults: 2 tablets orally daily in the morning and noon, may be increased in severe cases
- Elderly patients: 1 tablet in the morning
- Maintenance dose: Usually 1 tablet orally in the morning
Interaction
May enhance the response to alcohol, barbiturates, and other CNS depressants. Simultaneous administration of MAO-inhibitors may cause hypertensive crises
Contraindications
- Immediate recovery phase after myocardial infarction
- Defects in bundle-branch conduction
- Untreated narrow-angle glaucoma
- Acute alcohol, barbiturate and opiate intoxications
- Not recommended for excitable or overactive patients
- Patients who have received an MAO-inhibitor within two weeks
Side Effects
Rare in recommended doses, transient restlessness and insomnia
Pregnancy & Lactation
Preferably not given during pregnancy and lactation
Precautions & Warnings
If previously treated with tranquillizers with sedative effect, should be withdrawn gradually
Overdose Effects
Symptomatic and supportive, gastric lavage, activated charcoal, measures to support respiratory and cardiovascular systems, convulsions may be treated with diazepam and extrapyramidal symptoms with biperiden
Therapeutic Class
Combined anxiolytics & anti-depressant drugs
Storage Conditions
Store at a temperature not exceeding 30°C in a dry place. Protect from light.